Silexion Therapeutics Corp Ordinary Shares (SLXN) Technical Analysis
$0.34
Insights
- Silexion Therapeutics Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Silexion Therapeutics Corp stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Silexion Therapeutics Corp stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Silexion Therapeutics Corp stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 19.63 | Buy |
Stochastic | 2.5, 2.04 | Buy |
Ultimate Oscillator | 23.23 | Buy |
Stochastic Relative Strength Index | 65.88, 75.57 | Neutral |
Moving Average Convergence Divergence | -0.39, -0.47 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.36 | Sell |
20 | 0.48 | Sell |
50 | 1.62 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.4 | Sell |
20 | 0.65 | Sell |
50 | 1.66 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.37 | Sell |
20 | 0.57 | Sell |
50 | 0.81 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.26 | Buy |
20 | 0.08 | Buy |
50 | -0.15 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.37 | Buy |
20 | 0.18 | Buy |
50 | -0.01 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.39 |
Resistance L2 | 0.38 |
Resistance L1 | 0.37 |
Pivot Point | 0.36 |
Support L1 | 0.34 |
Support L2 | 0.34 |
Support L3 | 0.32 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.